Cymabay Therapeu Price History
| CBAYDelisted Stock | USD 11.83 0.27 2.34% |
If you're considering investing in Cymabay Stock, it is important to understand the factors that can impact its price. As of today, the current price of Cymabay Therapeu stands at 11.83, as last reported on the 1st of December, with the highest price reaching 12.43 and the lowest price hitting 11.52 during the day. We have found nine technical indicators for Cymabay Therapeu, which you can use to evaluate the volatility of the firm. Please confirm Cymabay Therapeu's Accumulation Distribution of 0.0732, rate of daily change of 1.02, and Day Typical Price of 11.93 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
Cymabay Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Cymabay |
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| CBAY |
Based on monthly moving average Cymabay Therapeu is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cymabay Therapeu by adding Cymabay Therapeu to a well-diversified portfolio.
Cymabay Therapeu Stock Price History Chart
There are several ways to analyze Cymabay Stock price data. The simplest method is using a basic Cymabay candlestick price chart, which shows Cymabay Therapeu price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Cymabay Stock Price History Data
| Open | High | Low | Close | Volume | ||
12/01/2024 | 11.56 | 12.43 | 11.52 | 11.83 | ||
| 07/24/2023 | 11.56 | 12.43 | 11.52 | 11.83 | 2,069,235 | |
| 07/21/2023 | 11.22 | 11.70 | 11.22 | 11.58 | 856,475 | |
| 07/20/2023 | 11.78 | 11.90 | 11.25 | 11.27 | 947,884 | |
| 07/19/2023 | 11.61 | 12.12 | 11.49 | 11.76 | 1,342,475 | |
| 07/18/2023 | 11.63 | 11.82 | 11.10 | 11.72 | 1,077,500 | |
| 07/17/2023 | 11.59 | 12.33 | 11.59 | 11.63 | 1,292,868 | |
| 07/14/2023 | 11.81 | 11.93 | 11.41 | 11.59 | 1,403,186 | |
| 07/13/2023 | 11.07 | 11.94 | 10.97 | 11.82 | 1,563,445 | |
| 07/12/2023 | 10.99 | 11.26 | 10.89 | 11.04 | 1,293,499 | |
| 07/11/2023 | 10.90 | 11.06 | 10.74 | 10.94 | 970,351 | |
| 07/10/2023 | 11.18 | 11.21 | 10.72 | 10.86 | 1,270,105 | |
| 07/07/2023 | 11.40 | 11.55 | 11.00 | 11.16 | 1,317,198 | |
| 07/06/2023 | 11.03 | 11.48 | 10.77 | 11.43 | 1,830,532 | |
| 07/05/2023 | 11.74 | 12.25 | 11.02 | 11.06 | 2,806,983 | |
| 07/03/2023 | 11.05 | 11.96 | 10.96 | 11.70 | 2,859,460 | |
| 06/30/2023 | 10.05 | 11.38 | 10.00 | 10.95 | 18,154,233 | |
| 06/29/2023 | 8.08 | 8.14 | 7.78 | 7.84 | 1,206,810 | |
| 06/28/2023 | 7.49 | 8.15 | 7.45 | 8.08 | 1,810,891 | |
| 06/27/2023 | 7.63 | 7.63 | 7.26 | 7.47 | 1,771,760 | |
| 06/26/2023 | 7.87 | 7.91 | 7.37 | 7.53 | 2,078,031 | |
| 06/23/2023 | 8.36 | 8.39 | 7.76 | 7.95 | 14,573,635 | |
| 06/22/2023 | 8.42 | 8.65 | 8.35 | 8.42 | 1,310,191 | |
| 06/21/2023 | 8.38 | 8.56 | 8.26 | 8.42 | 1,256,321 | |
| 06/20/2023 | 8.11 | 8.51 | 8.09 | 8.41 | 1,181,913 | |
| 06/16/2023 | 8.42 | 8.49 | 8.07 | 8.17 | 1,377,543 | |
| 06/15/2023 | 8.54 | 8.75 | 8.35 | 8.41 | 1,586,747 | |
| 06/14/2023 | 9.03 | 9.06 | 8.70 | 8.72 | 857,042 | |
| 06/13/2023 | 9.05 | 9.15 | 8.96 | 9.03 | 762,606 | |
| 06/12/2023 | 9.16 | 9.28 | 8.95 | 9.02 | 859,263 | |
| 06/09/2023 | 9.30 | 9.43 | 9.10 | 9.16 | 1,091,700 | |
| 06/08/2023 | 9.39 | 9.51 | 9.29 | 9.31 | 673,597 | |
| 06/07/2023 | 9.46 | 9.63 | 9.36 | 9.42 | 716,250 | |
| 06/06/2023 | 9.61 | 9.64 | 9.41 | 9.45 | 1,249,318 | |
| 06/05/2023 | 9.38 | 9.62 | 9.33 | 9.60 | 915,717 | |
| 06/02/2023 | 9.35 | 9.50 | 9.13 | 9.41 | 736,564 | |
| 06/01/2023 | 8.98 | 9.44 | 8.90 | 9.30 | 1,160,561 | |
| 05/31/2023 | 8.83 | 9.07 | 8.78 | 8.98 | 2,037,917 | |
| 05/30/2023 | 8.76 | 9.00 | 8.74 | 8.84 | 841,375 | |
| 05/26/2023 | 8.54 | 8.84 | 8.53 | 8.75 | 558,126 | |
| 05/25/2023 | 8.54 | 8.68 | 8.39 | 8.55 | 1,083,728 | |
| 05/24/2023 | 8.58 | 8.64 | 8.39 | 8.50 | 959,600 | |
| 05/23/2023 | 8.80 | 9.07 | 8.49 | 8.61 | 1,566,961 | |
| 05/22/2023 | 9.07 | 9.27 | 8.68 | 8.76 | 1,296,973 | |
| 05/19/2023 | 9.05 | 9.20 | 8.93 | 9.11 | 1,382,680 | |
| 05/18/2023 | 9.15 | 9.29 | 9.00 | 9.05 | 1,099,050 | |
| 05/17/2023 | 9.52 | 9.55 | 8.93 | 9.16 | 2,662,538 | |
| 05/16/2023 | 10.13 | 10.18 | 9.13 | 9.60 | 3,715,908 | |
| 05/15/2023 | 10.27 | 10.66 | 10.20 | 10.40 | 1,390,911 | |
| 05/12/2023 | 10.29 | 10.31 | 10.00 | 10.25 | 636,100 | |
| 05/11/2023 | 10.60 | 10.64 | 10.17 | 10.29 | 1,049,017 | |
| 05/10/2023 | 10.45 | 10.68 | 10.33 | 10.60 | 1,531,125 | |
| 05/09/2023 | 10.08 | 10.44 | 9.99 | 10.43 | 750,950 | |
| 05/08/2023 | 10.55 | 10.64 | 10.18 | 10.19 | 1,282,481 | |
| 05/05/2023 | 10.36 | 10.58 | 10.29 | 10.51 | 979,517 | |
| 05/04/2023 | 10.28 | 10.30 | 9.82 | 10.27 | 680,861 | |
| 05/03/2023 | 10.13 | 10.42 | 9.99 | 10.27 | 1,033,027 | |
| 05/02/2023 | 10.84 | 11.06 | 10.10 | 10.11 | 937,141 | |
| 05/01/2023 | 10.69 | 11.22 | 10.69 | 10.83 | 1,496,341 | |
| 04/28/2023 | 10.30 | 11.00 | 10.30 | 10.76 | 1,496,756 | |
| 04/27/2023 | 10.19 | 10.41 | 10.01 | 10.30 | 1,019,648 |
About Cymabay Therapeu Stock history
Cymabay Therapeu investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cymabay is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cymabay Therapeu will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cymabay Therapeu stock prices may prove useful in developing a viable investing in Cymabay Therapeu
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. CymaBay Therapeutics, Inc. was incorporated in 1988 and is headquartered in Newark, California. Cymabay Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 59 people.
Cymabay Therapeu Stock Technical Analysis
Cymabay Therapeu technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in Cymabay Stock
If you are still planning to invest in Cymabay Therapeu check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cymabay Therapeu's history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |